A Study of Renal Autologous Cell Therapy™ (REACT) in Type 2 Diabetics With Chronic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02836574

Recruitment Status : Active, not recruiting

First Posted : July 19, 2016

Last Update Posted : May 20, 2021

Sponsor:

Collaborator:

CTI Clinical Trial and Consulting Services

Information provided by (Responsible Party):

ProKidney, LLC

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	May 2025
Estimated Study Completion Date :	May 2028

To Top